Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Article
  • Published:

Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis

Oncogene volume 39, pages 1246–1259 (2020)Cite this article

Subjects

Abstract

Germline mutations of DNA double-strand break (DSB) response and repair genes that drive tumorigenesis could be a major cause of prostate cancer (PCa) heritability. In this study, we demonstrated the role of novel exonuclease 5 (EXO5) gene in androgen-induced double strand breaks repair via homology-directed repair pathway and prostate tumorigenesis. Using whole-exome sequencing of samples from 20 PCa families, with three or more siblings diagnosed with metastatic PCa, we identified mutations in 31 genes involved in DSB response and repair. Among them, the L151P mutation in the exonuclease 5 (EXO5) gene was present in all affected siblings in three PCa families. We found two other EXO5 SNPs significantly associated with risk of PCa in cases-controls study from databases of genotype and phenotype (dbGaP), which are in linkage disequilibrium (D′ = 1) with Exo5 L151P found in PCa family. The L151 residue is conserved across diverse species and its mutation is deleterious for protein functions, as demonstrated by our bioinformatics analyses. The L151P mutation impairs the DNA repair function of EXO5 due to loss of nuclease activity, as well as failure of nuclear localization. CRISPR elimination of EXO5 in a PCa cell line impaired homology-directed recombination repair (HDR) and caused androgen-induced genomic instability, as indicated by frequent occurrence of the oncogenic fusion transcript TMPRSS2-ERG. Genetic and functional validation of the EXO5 mutations indicated that EXO5 is a risk gene for prostate tumorigenesis, likely due to its functions in HDR.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6
Fig. 7

Similar content being viewed by others

References

  1. Ciccia A, Elledge SJ. The DNA damage response: making it safe to play with knives. Mol Cell. 2010;40:179–204.

    CAS  PubMed  PubMed Central  Google Scholar 

  2. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57–70.

    CAS  PubMed  Google Scholar 

  3. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144:646–74.

    CAS  PubMed  Google Scholar 

  4. Nussenzweig A, Nussenzweig MC. Origin of chromosomal translocations in lymphoid cancer. Cell. 2010;141:27–38.

    CAS  PubMed  PubMed Central  Google Scholar 

  5. Cejka P. DNA end resection: nucleases team up with the right partners to initiate homologous recombination. J Biol Chem. 2015;290:22931–38.

    CAS  PubMed  PubMed Central  Google Scholar 

  6. Bennardo N, Cheng A, Huang N, Stark JM. Alternative-NHEJ is a mechanistically distinct pathway of mammalian chromosome break repair. PLoS Genet. 2008;4:e1000110.

    PubMed  PubMed Central  Google Scholar 

  7. Liao S, Tammaro M, Yan H. The structure of ends determines the pathway choice and Mre11 nuclease dependency of DNA double-strand break repair. Nucl Acid Res. 2016;44:5689–701.

    CAS  Google Scholar 

  8. Zhu Z, Chung WH, Shim EY, Lee SE, Ira G. Sgs1 helicase and two nucleases Dna2 and Exo1 resect DNA double-strand break ends. Cell. 2008;134:981–94.

    CAS  PubMed  PubMed Central  Google Scholar 

  9. Garcia V, Phelps SE, Gray S, Neale MJ. Bidirectional resection of DNA double-strand breaks by Mre11 and Exo1. Nature. 2011;479:241–4.

    CAS  PubMed  PubMed Central  Google Scholar 

  10. Broderick R, Nieminuszczy J, Baddock HT, Deshpande R, Gileadi O, Paull TT, et al. EXD2 promotes homologous recombination by facilitating DNA end resection. Nat Cell Biol. 2016;18:271–80.

    CAS  PubMed  PubMed Central  Google Scholar 

  11. Sishc BJ, Davis AJ. The role of the core non-homologous end joining factors in carcinogenesis and cancer. Cancers. 2017;9:81–110.

    PubMed Central  Google Scholar 

  12. Haffner MC, Aryee MJ, Toubaji A, Esopi DM, Albadine R, Gurel B, et al. Androgen-induced TOP2B-mediated double-strand breaks and prostate cancer gene rearrangements. Nat Genet. 2010;42:668–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  13. Lin C, Yang L, Tanasa B, Hutt K, Ju BG, Ohgi K, et al. Nuclear receptor-induced chromosomal proximity and DNA breaks underlie specific translocations in cancer. Cell. 2009;139:1069–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  14. Alvarez-Quilon A, Serrano-Benitez A, Lieberman JA, Quintero C, Sanchez-Gutierrez D, Escudero LM, et al. (2014) ATM specifically mediates repair of double-strand breaks with blocked DNA ends. Nat Commun. 2014;5:3347.

    PubMed  Google Scholar 

  15. Hoa NN, Shimizu T, Zhou ZW, Wang ZQ, Deshpande RA, Paull TT, et al. Mre11 is essential for the removal of lethal topoisomerase 2 covalent cleavage complexes. Mol Cell. 2016;64:580–92.

    CAS  PubMed  Google Scholar 

  16. Wang J, Cai Y, Ren C, Ittmann M. Expression of variant TMPRSS2/ERG fusion messenger RNAs is associated with aggressive prostate cancer. Can Res. 2006;66:8347–51.

    CAS  Google Scholar 

  17. Sparks JL, Kumar R, Singh M, Wold MS, Pandita TK, Burgers PM. Human exonuclease 5 is a novel sliding exonuclease required for genome stability. J Biol Chem. 2012;287:42773–83.

    CAS  PubMed  PubMed Central  Google Scholar 

  18. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Prot. 2009;4:44–57.

    Google Scholar 

  19. Wood RD, Mitchell M, Lindahl T. Human DNA repair genes. Mut Res. 2005;577:275–83.

    CAS  Google Scholar 

  20. Milanowska K, Krwawicz J, Papaj G, Kosinski J, Poleszak K, Lesiak J, et al. REPAIRtoire-a database of DNA repair pathways. Nucl Acid Res. 2011;39:D788–92.

    CAS  Google Scholar 

  21. Andres-Leon E, Cases I, Arcas A, Rojas AM. DDRprot: a database of DNA damage response-related proteins. Database: the journal of biological databases and curation, 2016.

  22. Ng PC, Henikoff S. SIFT: Predicting amino acid changes that affect protein function. Nucl Acid Res. 2003;31:3812–4.

    CAS  Google Scholar 

  23. Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Meth. 2010;7:248–9.

    CAS  Google Scholar 

  24. Chun S, Fay JC. Identification of deleterious mutations within three human genomes. Genome Res. 2009;19:1553–61.

    CAS  PubMed  PubMed Central  Google Scholar 

  25. Schwarz JM, Rodelsperger C, Schuelke M, Seelow D. MutationTaster evaluates disease-causing potential of sequence alterations. Nat Meth. 2010;7:575–6.

    CAS  Google Scholar 

  26. Reva B, Antipin Y, Sander C. Predicting the functional impact of protein mutations: application to cancer genomics. Nucl Acid Res. 2011;39:e118.

    CAS  Google Scholar 

  27. Kircher M, Witten DM, Jain P, O’Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014;46:310–5.

    CAS  PubMed  PubMed Central  Google Scholar 

  28. Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, et al. PLINK: a tool set for whole-genome association and population-based linkage analyses. AJHG. 2007;81:559–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  29. Cancer Genome Atlas Research. The molecular taxonomy of primary prostate cancer. Cell. 2015;163:1011–25.

    Google Scholar 

  30. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, et al. The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012;2:401–4.

    PubMed  Google Scholar 

  31. Bienert S, Waterhouse A, de Beer TA, Tauriello G, Studer G, Bordoli L, et al. The SWISS-MODEL Repository-new features and functionality. Nucl Acid Res. 2017;45:D313–D319.

    CAS  Google Scholar 

  32. la Cour T, Kiemer L, Molgaard A, Gupta R, Skriver K, Brunak S. Analysis and prediction of leucine-rich nuclear export signals. Protein Eng Des Selection. 2004;17:527–36.

    Google Scholar 

  33. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, Zhang F. Genome engineering using the CRISPR-Cas9 system. Nat Prot. 2013;8:2281–308.

    CAS  Google Scholar 

  34. Gunn A, Stark JM. I-SceI-based assays to examine distinct repair outcomes of mammalian chromosomal double strand breaks. Methods Mol Biol. 2012;920:379–91.

    CAS  PubMed  Google Scholar 

  35. Chen CC, Avdievich E, Zhang Y, Zhang Y, Wei K, Lee K, et al. EXO1 suppresses double-strand break induced homologous recombination between diverged sequences in mammalian cells. DNA Repair. 2017;57:98–106.

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Mimitou EP, Symington LS. Sae2, Exo1 and Sgs1 collaborate in DNA double-strand break processing. Nature. 2008;455:770–74.

    CAS  PubMed  Google Scholar 

  37. Howard SM, Yanez DA, Stark JM. DNA damage response factors from diverse pathways, including DNA crosslink repair, mediate alternative end joining. PLoS Genet. 2015;11:e1004943.

    PubMed  PubMed Central  Google Scholar 

  38. Forment JV, Walker RV, Jackson SP. A high-throughput, flow cytometry-based method to quantify DNA-end resection in mammalian cells. Cytom Part A: J Int Soc Anal Cytol. 2012;81:922–28.

    Google Scholar 

  39. Tomlins SA, Rhodes DR, Perner S, Dhanasekaran SM, Mehra R, Sun XW, et al. Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer. Science. 2005;310:644–8.

    CAS  PubMed  Google Scholar 

  40. Carter BS, Beaty TH, Steinberg GD, Childs B, Walsh PC. Mendelian inheritance of familial prostate cancer. Proc Natl Acad Sci USA. 1992;89:3367–71.

    CAS  PubMed  PubMed Central  Google Scholar 

  41. Pritchard CC, Mateo J, Walsh MF, De Sarkar N, Abida W, Beltran H, et al. Inherited DNA-repair gene mutations in men with metastatic prostate cancer. N Engl J Med. 2016;375:443–53.

    CAS  PubMed  PubMed Central  Google Scholar 

  42. Stanford JL, Ostrander EA. Familial prostate cancer. Epidemiol Rev. 2001;23:19–23.

    CAS  PubMed  Google Scholar 

  43. Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate. 1990;17:337–47.

    CAS  PubMed  Google Scholar 

  44. Al Olama AA, Kote-Jarai Z, Berndt SI, Conti DV, Schumacher F, Han Y, et al. A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer. Nat Genet. 2014;46:1103–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  45. Amin Al Olama A, Kote-Jarai Z, Schumacher FR, Wiklund F, Berndt SI, Benlloch S, et al. A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease. Hum Mol Genet. 2013;22:408–15.

    CAS  PubMed  Google Scholar 

  46. Gudmundsson J, Sulem P, Gudbjartsson DF, Masson G, Agnarsson BA, Benediktsdottir KR, et al. A study based on whole-genome sequencing yields a rare variant at 8q24 associated with prostate cancer. Nat Genet. 2012;44:1326–9.

    CAS  PubMed  PubMed Central  Google Scholar 

  47. Schumacher FR, Berndt SI, Siddiq A, Jacobs KB, Wang Z, Lindstrom S, et al. Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet. 2011;20:3867–75.

    CAS  PubMed  PubMed Central  Google Scholar 

  48. Yeager M, Chatterjee N, Ciampa J, Jacobs KB, Gonzalez-Bosquet J, Hayes RB, et al. Identification of a new prostate cancer susceptibility locus on chromosome 8q24. Nat Genet. 2009;41:1055–7.

    CAS  PubMed  PubMed Central  Google Scholar 

  49. Eeles RA, Kote-Jarai Z, Giles GG, Olama AA, Guy M, Jugurnauth SK, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40:316–21.

    CAS  PubMed  Google Scholar 

  50. Zheng SL, Liu W, Wiklund F, Dimitrov L, Balter K, Sun J, et al. A comprehensive association study for genes in inflammation pathway provides support for their roles in prostate cancer risk in the CAPS study. Prostate. 2006;66:1556–64.

    CAS  PubMed  Google Scholar 

  51. Leongamornlert D, Saunders E, Dadaev T, Tymrakiewicz M, Goh C, Jugurnauth-Little S, et al. Frequent germline deleterious mutations in DNA repair genes in familial prostate cancer cases are associated with advanced disease. Br J Can. 2014;110:1663–72.

    CAS  Google Scholar 

  52. Mucci LA, Hjelmborg JB, Harris JR, Czene K, Havelick DJ, Scheike T, et al. Familial risk and heritability of cancer among twins in Nordic Countries. JAMA. 2016;315:68–76.

    CAS  PubMed  PubMed Central  Google Scholar 

  53. Merajver SD, Frank TS, Xu J, Pham TM, Calzone KA, Bennett-Baker P, et al. Germline BRCA1 mutations and loss of the wild-type allele in tumors from families with early onset breast and ovarian cancer. Clin Can Res. 1995;1:539–44.

    CAS  Google Scholar 

  54. Cavenee WK, Dryja TP, Phillips RA, Benedict WF, Godbout R, Gallie BL, et al. Expression of recessive alleles by chromosomal mechanisms in retinoblastoma. Nature. 1983;305:779–84.

    CAS  PubMed  Google Scholar 

  55. Santarosa M, Ashworth A. (2004) Haploinsufficiency for tumour suppressor genes: when you don’t need to go all the way. BBA. 2004;1654:105–22.

    CAS  PubMed  Google Scholar 

  56. Wilson S, Qi J, Filipp FV. Refinement of the androgen response element based on ChIP-Seq in androgen-insensitive and androgen-responsive prostate cancer cell lines. Sci Rep. 2016;6:32611.

    CAS  PubMed  PubMed Central  Google Scholar 

  57. St John J, Powell K, Conley-Lacomb MK, Chinni SR. TMPRSS2-ERG fusion gene expression in prostate tumor cells and its clinical and biological significance in prostate cancer progression. J Cancer Sci Ther. 2012;4:94–101.

    Google Scholar 

Download references

Acknowledgements

We acknowledge Dr. Theodore Krontiris and Dr. Ching Ouyang in City of Hope for providing the genomic DNA samples of prostate cancer families. We thank Charles Warden and Dr. Xiwei Wu for their help in genomic data deposition. Drs. Keely Walker and Kerin K. Higa for proofreading the manuscript. Research reported in this publication included work performed in the Computational Therapeutics and Integrative Genomics core facilities, which are supported by the National Cancer Institute of the National Institutes of Health under award number P30CA033572. The work was partially supported by City of Hope institutional Excellence Award to B.H.S.

Financial support:

The work is supported by City of Hope institutional Excellence Award.

Author information

Authors and Affiliations

  1. Department of Cancer Genetics and Epigenetics, Beckman Research Institute of City of Hope, Duarte, USA

    Shafat Ali, Yilan Zhang, Mian Zhou, Weiwei Jin, Li Zheng, Xiaochun Yu, Jeremy M. Stark & Binghui Shen

  2. Department of Molecular Medicine, Beckman Research Institute of City of Hope, Duarte, USA

    Hongzhi Li

  3. Department of Population Sciences, Beckman Research Institute of City of Hope, Duarte, CA, 91010, USA

    Jeffrey N. Weitzel

Authors
  1. Shafat Ali
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yilan Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Mian Zhou
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hongzhi Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Weiwei Jin
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Li Zheng
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Xiaochun Yu
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Jeremy M. Stark
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Jeffrey N. Weitzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Binghui Shen
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Binghui Shen.

Ethics declarations

Conflict of interest

The authors declare no conflict of interest.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ali, S., Zhang, Y., Zhou, M. et al. Functional deficiency of DNA repair gene EXO5 results in androgen-induced genomic instability and prostate tumorigenesis. Oncogene 39, 1246–1259 (2020). https://doi.org/10.1038/s41388-019-1061-6

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41388-019-1061-6

Search

Advanced search

Quick links